Fluoxymesterone
Autre nom：Halotestin
CAS register number：76-43-7
EINECS：200-961-8
Formule moléculaire：C20H29FO3
Masse moléculaire：336.44
Point de fusion：240 °C
Essai：97.0~103.0%
Usage：Treating a deficiency of the male hormone testosterone when the body does not make enough. used to stimulate puberty in males with delayed puberty. Treating advanced breast cancer in women who are 1 à 5 years past menopause.
Fluoxymesterone is a synthetic derivative of Testosterone, but it is in particular actually a derivative of Methyltestosterone (Testosterone that has been Methylated).
It is generally regarded as a very strong oral anabolic steroid that is unable to aromatize into Estrogen and also exhibits very strong androgenic strength as well.
Effects
maintenance and gaining of lean mass and tissue repair following various conditions of trauma (burns, bone fractures, malnutrition, muscle-wasting diseases, treatment of paraplegics, and as an adjunct to chronic administration of corticosteroids).
Males its use was indicated for the treatment of insufficient androgen production (hypogonadism or andropause).
In females, Halo would be approved for use in treating chronic dysfunctional uterine bleeding as well as female breast cancer.
Halotestin will exert performance enhancing benefits without the unwanted increases in weight that may slow down an athlete, such as a sprinter, who requires the least weight as possible in order to maximize speed efficiency while still receiving that benefit of performance enhancement.
